Jinyu Bio-technology Future Growth
Future criteria checks 5/6
Jinyu Bio-technology is forecast to grow earnings and revenue by 24.7% and 20.2% per annum respectively. EPS is expected to grow by 23.8% per annum. Return on equity is forecast to be 8.1% in 3 years.
Key information
24.7%
Earnings growth rate
23.8%
EPS growth rate
Biotechs earnings growth | 33.3% |
Revenue growth rate | 20.2% |
Future return on equity | 8.1% |
Analyst coverage | Good |
Last updated | 03 May 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 2,750 | 574 | N/A | 651 | 3 |
12/31/2025 | 2,331 | 461 | 271 | 488 | 10 |
12/31/2024 | 1,847 | 363 | 175 | 491 | 5 |
3/31/2024 | 1,582 | 283 | 223 | 496 | N/A |
12/31/2023 | 1,598 | 284 | 142 | 415 | N/A |
9/30/2023 | 1,639 | 289 | 221 | 429 | N/A |
6/30/2023 | 1,572 | 240 | 280 | 445 | N/A |
3/31/2023 | 1,551 | 236 | 151 | 331 | N/A |
12/31/2022 | 1,529 | 211 | 155 | 345 | N/A |
9/30/2022 | 1,546 | 174 | 233 | 486 | N/A |
6/30/2022 | 1,578 | 229 | 188 | 493 | N/A |
3/31/2022 | 1,599 | 252 | 124 | 484 | N/A |
12/31/2021 | 1,776 | 382 | 160 | 533 | N/A |
9/30/2021 | 1,813 | 529 | 245 | 554 | N/A |
6/30/2021 | 1,798 | 482 | 379 | 673 | N/A |
3/31/2021 | 1,735 | 467 | 446 | 677 | N/A |
12/31/2020 | 1,582 | 406 | 471 | 700 | N/A |
9/30/2020 | 1,387 | 268 | 415 | 684 | N/A |
6/30/2020 | 1,240 | 234 | 209 | 481 | N/A |
3/31/2020 | 1,159 | 213 | 239 | 526 | N/A |
12/31/2019 | 1,127 | 221 | 98 | 405 | N/A |
9/30/2019 | 1,312 | 322 | -13 | 349 | N/A |
6/30/2019 | 1,646 | 565 | -63 | 408 | N/A |
3/31/2019 | 1,673 | 617 | -221 | 293 | N/A |
12/31/2018 | 1,897 | 754 | -123 | 422 | N/A |
9/30/2018 | 2,008 | 869 | 196 | 636 | N/A |
6/30/2018 | 1,909 | 842 | 257 | 713 | N/A |
3/31/2018 | 1,997 | 900 | 381 | 840 | N/A |
12/31/2017 | 1,901 | 870 | N/A | 945 | N/A |
9/30/2017 | 1,809 | 842 | N/A | 935 | N/A |
6/30/2017 | 1,651 | 748 | N/A | 910 | N/A |
3/31/2017 | 1,635 | 719 | N/A | 824 | N/A |
12/31/2016 | 1,517 | 645 | N/A | 756 | N/A |
9/30/2016 | 1,393 | 561 | N/A | 764 | N/A |
6/30/2016 | 1,309 | 518 | N/A | 588 | N/A |
3/31/2016 | 1,252 | 505 | N/A | 583 | N/A |
12/31/2015 | 1,247 | 480 | N/A | 494 | N/A |
9/30/2015 | 1,210 | 499 | N/A | 389 | N/A |
6/30/2015 | 1,116 | 436 | N/A | 501 | N/A |
3/31/2015 | 1,063 | 433 | N/A | 460 | N/A |
12/31/2014 | 1,063 | 404 | N/A | 585 | N/A |
9/30/2014 | 921 | 346 | N/A | 837 | N/A |
6/30/2014 | 874 | 308 | N/A | 785 | N/A |
3/31/2014 | 849 | 277 | N/A | 809 | N/A |
12/31/2013 | 671 | 251 | N/A | 649 | N/A |
9/30/2013 | 628 | 243 | N/A | 312 | N/A |
6/30/2013 | 602 | 223 | N/A | 220 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 600201's forecast earnings growth (24.7% per year) is above the savings rate (2.9%).
Earnings vs Market: 600201's earnings (24.7% per year) are forecast to grow faster than the CN market (23.8% per year).
High Growth Earnings: 600201's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 600201's revenue (20.2% per year) is forecast to grow faster than the CN market (14.4% per year).
High Growth Revenue: 600201's revenue (20.2% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 600201's Return on Equity is forecast to be low in 3 years time (8.1%).